To test the hypothesis that intracellular cAMP has a regulatory role in cardiac slow channel function, intracellular pressure injections of cAMP and adenylate cyclase activators, Gpp(NH)p and cholera toxin, were carried out. Guinea pig papillary muscles were depolarized to about -45 mV by supervision with 22 rrtM K + -Tyrode's solution to inactivate the fast Na + channels. Induction of slow action potentials or enhancement of ongoing slow action potentials was observed in about 70% of all cells in which a successful intracellular injection of the testing compounds was obtained. The slow AP is highly dependent on slow inward current and is known to be enhanced by catecholamines. The effect of the injected cyclic nucleotides and related compounds occurred within 3 minutes after starting the injection, whereas superfusion with these compounds (dibutyryl cAMP was used in place of cAMP) required 10-30 minutes to show an effect. This difference is attributed to the intracellular injection of the compound. The effect on stimulating slow action potentials persisted (>5 minutes) after termination of the application of either Gpp(NH)p or cholera toxin, indicating the long-lasting nature of their action. The effect of the cAMP injections decayed within 1 minute. Intracellular injection of 5'-AMP was without effect. These results support the view that a causal relationship exists between intracellular cAMP level and slow channel function. Phosphorylation of a protein constituent of the slow channel by a cAMP-dependent protein kinase may be involved. (Circ Res 52: 111-117, 1983) 
SUMMARY. To test the hypothesis that intracellular cAMP has a regulatory role in cardiac slow channel function, intracellular pressure injections of cAMP and adenylate cyclase activators, Gpp(NH)p and cholera toxin, were carried out. Guinea pig papillary muscles were depolarized to about -45 mV by supervision with 22 rrtM K + -Tyrode's solution to inactivate the fast Na + channels. Induction of slow action potentials or enhancement of ongoing slow action potentials was observed in about 70% of all cells in which a successful intracellular injection of the testing compounds was obtained. The slow AP is highly dependent on slow inward current and is known to be enhanced by catecholamines. The effect of the injected cyclic nucleotides and related compounds occurred within 3 minutes after starting the injection, whereas superfusion with these compounds (dibutyryl cAMP was used in place of cAMP) required 10-30 minutes to show an effect. This difference is attributed to the intracellular injection of the compound. The effect on stimulating slow action potentials persisted (>5 minutes) after termination of the application of either Gpp(NH)p or cholera toxin, indicating the long-lasting nature of their action. The effect of the cAMP injections decayed within 1 minute. Intracellular injection of 5'-AMP was without effect. These results support the view that a causal relationship exists between intracellular cAMP level and slow channel function. Phosphorylation of a protein constituent of the slow channel by a cAMP-dependent protein kinase may be involved. (Circ Res 52: [111] [112] [113] [114] [115] [116] [117] 1983) ACTIVATION of adenylate cyclase/cAMP system mediates the /?-adrenergic effects in heart muscles (Sutherland et al., 1968) . In cardiac muscle, catecholamines enhance the slow inward current (I s i) carried largely by Ca ++ , as seen by voltage clamp experiments (e.g., Reuter and Scholz, 1977a ). An increase in Ca ++ influx is believed to be causally related to positive inotropic actions. The activation/inactivation kinetics of I S i was not changed by /S-adrenergic agonists, suggesting that the increase in I S j was due to an increase in density of functional slow channels (Reuter and Scholz, 1977b) .
Excitability in the form of slow action potential (AP) could be restored in heart tissues whose fast Na + channels had been blocked by TTX or in elevated [K] o by addition of the more membrane permeable N 8 , O 2 -dibutyryl cAMP (db-cAMP) (Shigenobu and Sperelakis, 1972; Watanabe and Besch, 1974) . The slow APs are slowly rising (V ma x ~ 10-20 V/sec) and are induced or enhanced by catecholamines and methylxanthines (Pappano, 1970; Shigenobu and Sperelakis, 1972) . The overshoot and V ma , of the slow APs are sensitive to [Ca] o . The slow APs are blocked by the slow channel blockers, such as Mn ++ and verapamil. The slow AP has been used as a convenient measure of I s i-To characterize the involvement of cAMP in slow channel function, it is necessary to increase intracellular cAMP level with bypass of the ^-receptors.
However, exogenous cAMP is not readily permeable through the membrane (Robison et al., 1965) . In addition to db-cAMP, other means to augment I S i independent of the /J-receptor, presumably through an increase in intracellular cAMP, include: (1) histamine, an adenylate cyclase stimulator via the H2 receptor (Inui and Imamura, 1976; Josephson et al., 1976) ; (2) phosphodiesterase inhibitors, which prevent the enzyme from hydrolyzing cAMP to 5'-AMP, resulting in an increase in cAMP level, such as methylxanthines (Shigenobu and Sperelakis, 1972; Tsien et al., 1972) , papaverine (Watanabe and Besch, 1974; Schneider et al., 1975) , and RO -7-2956 (Tritthart et al., 1975) ; (3) Gpp(NH)p, an analogue of GTP which is required for adenylate cyclase activation. Binding of Gpp(NH)p to the enzyme is nonhydrolyzable, resulting in a sustained enzyme activation (Lefkowitz, 1974; Josephson and Sperelakis, 1978) . However, the interpretation of the results obtained from using these compounds is complicated because secondary effects have been reported for cAMP derivatives (Miller et al., 1973) and phosphodiesterase inhibitors (Kukovetz et al., 1975) .
Iontophoresis of cAMP into cardiac Purkinje fibers increased the amplitude of the AP plateau and decreased AP duration (Tsien, 1973) , thus mimicking the effect of externally applied adrenaline. By intracellular iontophoresis of cAMP, Vogel and Sperelakis (1981) were able to induce or enhance slow APs in partially depolarized dog Purkinje fibers and guinea pig papillary muscles. This is probably the most direct evidence for a linkage between cAMP and slow channel activation.
In the present study, we used intracellular pressure injection technique to demonstrate further the relationship between cAMP and function of the slow channels in cardiac muscle. cAMP, Gpp(NH)p, and cholera toxin were injected. Both Gpp(NH)p and cholera toxin are potent adenylate cyclase activators. Cholera toxin is a protein (MW ~ 84,000 daltons) believed to be involved in the inhibition of GTP hydrolysis and thereby maintains adenylate cyclase in the activated state (Lai, 1980) . Our data support a role of cAMP in slow channel function. A preliminary report has been published in abstract form (Li and Sperelakis, 1982) .
Methods

Tissue Preparation and Superfusion
Guinea pigs (250-300 g, both sexes) were used for the experiments. Small papillary muscles, less than 1 mm in diameter and about 2 mm long, taken from right ventricle were pinned to a tissue chamber (volume of 0.6 ml) and superfused with Tyrode's solution (37°C, pH 7.4) at a flow rate of 1.5 ml/min. The composition of the Tyrode's solution was (in miu): 136.9 NaCI, 5.4 KC1, 11.9 NaHCO 3 , 0.2 NaH 2 PO 4 , 1.0 MgCI 2 , 1.8 CaCl 2 , 5.5 glucose. Elevated K + solution was prepared by increasing the KC1 concentration to 22 mM. The solutions were saturated with 95% O 2 and 5% CO2. The tissue was equilibrated in Tyrode's solution for at least 60 minutes under constant electrical stimulation of 1 Hz before experiments were started.
Electrical Stimulation and Intracellular Microeiectrode Recordings
One stimulating electrode was a thin glass tubing (0.6 mm o.d.) filled with Tyrode's solution, pressed directly against the papillary muscle so as to reduce the voltage required for stimulation. The other electrode was a platinum plate placed 2-3 mm away from the preparation. A Grass S88 stimulator and an isolation unit were used to deliver electrical stimuli (square waves 2 msec in duration and with an amplitude 20% above threshold voltage) to elicit APs at 1 Hz. In the elevated K + solution, a frequency of 0.5 Hz and greater voltage was applied to elicit the slow APs, because the slow APs had a longer refractoriness and higher threshold.
During the control period, fast APs and membrane potentials were recorded with micropipette (WPI) microelectrodes filled with 3 M KC1 (20-30 Mfi).
An agar salt-bridge containing 3 M KG was used as reference electrode, positioned near the chamber outflow so that any K + diffusion out of the salt bridge was flushed out. Both half-cells were Ag-AgCl wires. These electrodes were connected to a Dagan 8500 microeiectrode preamplifier (Dagan Corp.). An RC differentiator was used for differentiation of the APs (dV/dt). A Tektronix 5111 storage oscilloscope (Tektronix, Inc.) was used for display of the signals which were then photographed with a Grass kymograph camera.
Intracellular Pressure Injections
The pressure injection technique has several advantages over iontophoretic injections (Sakai et al., 1979) , such as:
(1) avoiding large polarizing currents which may cause damage to the cell, and (2) ability to inject non-charged molecules and large molecules. A Picospritzer (General Valve Corp.) connected to a compressed nitrogen tank was employed for pressure regulations (up to 100 psi). Simultaneous intracellular voltage recording and injection by the same microeiectrode were carried out. The injecting/recording microeiectrode (the regular fast-filling type, WPI) was prepared immediately before each experiment by filling with solution containing the substance to be injected and beveling to a resistance of 10 Mfi or less with a WPI beveling system. The beveling procedure allowed ease of cell penetration and fluid ejections. cAMP (Na + salt, 0.2-1.0 M), Gpp(NH)p (3-4 X 10"^ M, in 0.2 M NaCI), and cholera toxin (1 mg/ml reconstituted, containing 0.2 M NaCI) and Na-5'-AMP (1 M), all from Sigma Chemical, were used for filling the electrodes. The major conducting cation in the filling solution was Na + . Control experiments showed that injection of NaCI solution (up to 1 M) was without effect on inducing slow APs.
Ejection volumes were quantitated by measuring the diameter of aqueous droplets exuded into mineral oil (Sakai et al., 1979) . Although the relationship between ejected volume and either pressure or ejection time was usually linear, reliable estimates of volume injected into the cardiac cell was not possible. The major problems include the following: (1) The microeiectrode became easily clogged upon intracellular penetration. Increase in microeiectrode resistance was frequently observed during pressure application. (2) Ejection volume observed in air or oil is not necessarily the same as that which would occur in cells, because of the intracellular tissue pressure acting against the microeiectrode ejection. Thus, quantification of intracellular injection volume, so as to determine the amount of the material injected into the cell, was subject to enormous errors.
The following criteria were used for determining acceptance of data from the injection experiments: (1) A steady resting potential was maintained throughout the experimental period.
(2) Definite ejection of fluid was observed from the microeiectrode tip into air under a microscope before and after an injection experiment.
Results
Effect of cAMP
Superfusion Extracellular application of lipid-soluble db-cAMP induced slow APs or enhanced ongoing slow APs in guinea pig papillary muscle.
An example of the enhancement of an ongoing slow AP is illustrated in Figure 1 . A typical fast AP in normal Tyrode's solution (containing 5.4 mM [K] o ) is shown in Figure 1A . The resting potential was about -80 mV and V ma x was about 160 V/sec. Elevation of [K] o to 22 mM depolarized the cell to about -45 mV and inactivated the fast Na + channels. Slow APs (V max of about 5 V/sec) were induced by strong electrical stimulation (at 0.5 Hz) ( Fig. IB) . Superfusion with 1 mM db-cAMP gradually enhanced the slow AP ( Fig.  1 , C-E). It took more than 20 minutes to reach a steady state for potentiation of the slow APs (increase in amplitude, duration, and V max ).
Recovery from the effect of exposure to db-cAMP required a long time relatively. As shown in Figure  IF , the slow AP had not completely returned to control after a 25-minute washout period. Isoproterenol (ISO), 10" 6 M, exerted a similar qualitative effect as db-cAMP, but the effect was much more rapid (Fig. lG) .
Similar effects of the db-cAMP superfusion were observed in one other preparation, and induced slow APs in a third preparation.
Injection
The effect of pressure injection of cAMP was seen mostly as an enhancement of ongoing slow APs elicited by electrical stimulation. In a few instances, induction of slow APs also was observed. One example is shown in Figure 2 . Upon the onset of cAMP injection with a 0.2 M Na + -cAMP-filled microelectrode, slow APs appeared within 25 seconds from a lowlevel graded response (Fig. 2, A and B) . The slow AP is stabilized in 1 minute (Fig. 2C ). Recovery was also fast. Within 30 seconds after switching off the injection pressure, slow APs disappeared (Fig. 2, D and E) . Positive results with cAMP injections have been obtained in 48 cells out of 63 cells with successful injections (76%) in 16 preparations. In all of these successful experiments, the effect on slow AP induction/enhancement was first observed within 30 sec- onds after the start of cAMP injection, and whenever recovery from the cAMP-induced effect was followed, complete recovery was observed between 30 seconds to 3 minutes. These time courses are considerably shorter than those observed with extracellular applications of db-cAMP. As a control for the cAMP-injection experiments, intracellular injection of 5'-AMP also was carried out. Injection of 5'-AMP did not induce slow APs from a low-level graded membrane response (Fig. 3, B and C). In addition, injection of 5'-AMP did not enhance ongoing slow APs (Fig. 3, D and E) . Similar results were obtained in 10 successful injections in three different preparations. These results demonstrate not only the lack of effect of 5'-AMP, but also the lack of effect of the pressure injection itself, in stimulating slow APs. 
GUINEA-PIG PAPILLARY MUSCLE
Effect of Gpp(NH)p Superfusion
When Gpp(NH)p (10~4 M) was added to the elevated [K] o -Tyrode's solution, a slow enhancement of the slow APs was seen (Fig. 4) . The amplitude of the slow AP was significantly increased only after superfusion with Gpp(NH)p for 30 minutes (Fig. 4, B-D) . The recovery process was also relatively slow. Only slight decrease in the slow AP amplitude was observed after 10 minutes washout (Fig. 4E) . Greatly reduced slow APs occurred after 20 minutes (Fig. 4F) . A similar result was observed in another preparation.
Injection
Intracellular injection of Gpp(NH)p quickly induced slow APs. Figure 5 shows one example. In Figure 5A , a control AP in normal Tyrode's solution was seen. A microelectrode filled with ~3 X 10~2 M Gpp(NH)p -0.2 M NaCl was used for intracellular injections and membrane potential recordings. Figure  5B represents a preinjection graded membrane response. Figure 5 , C and D, shows the gradual appearance of slow APs at about 4 minutes and 5 minutes during a continuous injection. The induced slow APs were stabilized after 6 minutes (Fig. 5E ). The slow action potentials persisted 5 minutes after the injection was ceased (Fig. 5F ). Immediately after moving the microelectrode to a nearby parallel cell 25 ;um away from the injection site, slow AP activity to a lesser degree (smaller amplitude, failure to respond to all stimuli) was observed (Fig. 5G) . A cell 50 jum away did not show slow APs (Fig. 5H) . The last two records were obtained within 6 minutes after stopping the injection. Other experiments had shown that the slow APs induced by Gpp(NH)p injection lasted at Circulation Research/Vo/. 52, No. 1, January 1983 GUINEA-PIG PAPILLARY MUSCLE f\ L -L. 
. Stimulation of slow action potentials by superfusion with Cpp(NH)p. Panel A: Control fast action potential in normal Tyrode's solution (stimulation rate of 60/min). Panel B: Slow action potential induced in 22 mst KC1 by electric stimulation (30/min).
Panels C-D: Effect of superfusion of 10'' M Gpp(NH)p. The slow action potentials were significantly enhanced (e.g., increased amplitude) after 9 minutes of exposure to Gpp(NH)p (C). After about 30 minutes, steady state was reached (D) . Panels E-F: Upon washout of Gpp(NH)p, the slow action potential parameters gradually returned to control levels. Noticeable depression of the slow action potential was seen after 10 minutes washout (E). Greatly reduced slow action potentials were observed after 25 minutes washout (F). All records were obtained from one cell. Other experiments showed that the slow action potential induced by Gpp(NH)p injection was observed for at least 7 min after the injection was stopped.
least 7 minutes after stoppage of the injection. These results could mean a localized effect of the Gpp(NH)p injection. Positive results were seen in 26 cells from 39 cells with successful injections (67%) in 10 preparations.
Effect of Cholera Toxin
Superfusion
The effect of cholera toxin in the guinea pig papillary muscle cells was qualitatively similar to that of Gpp(NH)p. Extracellular application of cholera toxin (5 /tg/ml) enhanced the electrical stimulation induced slow APs in elevated [K] o -Tyrode's solution (Fig. 6) . Figure 6 , B-D, shows the gradual growth of the slow APs during the exposure to cholera toxin. Stable, large slow APs appeared nearly 1 hour after the start of superfusion of the toxin (Fig. 6E) . The effect induced by cholera toxin is also rather irreversible since the large slow APs could still be seen after 34 minutes washout (Fig. 6, F-G) , even though frequency of failure of the large slow APs was gradually increased. Confirming result was seen in another preparation. (D) . Stable large slow action potentials were obtained after 60 min superfusion with cholera toxin (E). Panels F-G: Effect of cholera toxin washout. Intermittent failure of the large slow action potentials occured after 10 min (F) . Although frequency of the failures was increased, the slow action potentials with long duration were still observed after 34 min of washout (G) . All records were obtained from one cell.
Injection
Pressure injection of cholera toxin (1 mg/ml) was effective in enhancing the slow APs within 30 seconds (Fig. 7, A and B) . The effect continued to grow ( Fig.  7C at 1 .5 minutes) during continuous injection to a steady state in about 3 minutes (Fig. 7D ). The effect persisted 4 minutes after injection was ceased (Fig.  7E ). Similar positive effect was observed in seven cells from 10 cells with successful injections (70%) in three preparations.
Discussion
Even though the hypothesis of a cAMP-dependent process in regulation of the cardiac slow channels has been proposed for some time (e.g., Sperelakis and Schneider, 1976) , this hypothesis has not been proven. The present findings provide strong support for a role of cAMP in slow channel function. Injections of cAMP, Gpp(NH)p, and cholera toxin were used in the present experiments to test the cAMP hypothesis. Since Gpp(NH)p activates adenylate cyclase by binding to the GTP regulatory site, and cholera toxin activates the enzyme by preventing GTP hydrolysis, both compounds should raise intracellular cAMP levels. Intracellular injection of all three compounds resulted in an induction or enhancement (increase in V mas and/or amplitude) of the slow AP in 22 mM K +depolarized myocardial cells. The effect of cAMP by pressure injection was similar to that by iontophoretic injection reported previously by Vogel and Sperelakis (1981) .
Positive results were obtained in 67-76% of all cells successfully injected. These rates of positive findings were quite satisfactory, considering the frequently encountered clogging of the microelectrodes and the uncertainty of the ejection volume.
The intracellular site for the stimulating effect (on the slow channels) by the three compounds tested is indicated by comparing the time course of their effects induced by intracellular injections and by extracellular applications. In the superfusion experiments, detectable enhancement of an ongoing slow AP was noticed only after 9 minutes of superfusion for all of the compounds, and a steady state enhancement was attained in 15-60 minutes. This is in agreement with the reported slow action of these compounds due to slow membrane penetration of db-cAMP (Skelton et al., 1970, Shigenobu and Sperelakis, 1972) , Gpp(NH)p (Josephson and Sperelakis, 1978) , and cholera toxin (Lai, 1980) . Intracellular application of these compounds, i.e., bypassing the membrane barrier, resulted in a much shorter lag time: a noticeable effect was usually seen within 1 minute (a majority occurred within 30 seconds), and steady state was reached in 1-6 minutes. A persisting effect of Gpp(NH)p and cholera toxin injection was observed for 4 minutes or longer after cessation of the injection. This reflects a somewhat irreversible activation of the adenylate cyclase by these two compounds. The rather short decay time (0.5-2 minutes) after cessation of cAMP injection was probably due to the activation of phosphodiesterase (which converts cAMP to the inactive 5'-AMP).
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FIGURE 7. Stimulation of slow action potentials by intracellular injection of cholera toxin. Panel A: Slow action potential induced by electrical stimulation (30/min) in 22 mM KCI. Panels B-D:
Effect of intracellular pressure injection of cholera toxin. A microelectrode filled with reconstituted cholera toxin (1 mg/ml) solution containing 0.2 M NaCl was used both for intracellular injections and membrane potential recordings. An enhancement of the slow action potential occured within 30 sec (B) of the commencement of the injection period. The amplitude and duration of the slow action potential continued to increase during the injection as seen at 1.5 min (C), until about 3 min (D) when an apparent steady-state was reached. Panel E: Persistent effect of cholera toxin after cessation of injection. The slow action potential remained enhanced 4 min after the injection had stopped. All records were obtained from one cell.
The persistence of the effect of extracellularly applied db-cAMP for a long time (>20 minutes, Fig. 1 ) after washout could be partly explained by its acting as a phosphodiesterase inhibitor (Miller et al., 1973) .
As to the mechanism of action of cAMP on slow channel function, it seems likely that enzymatic phosphorylation of a sarcolemmal protein is involved. cAMP activates a cAMP-dependent protein kinase (Krebs, 1972) , which, in turn, phosphorylates a variety of proteins. In isolated heart sarcolemma, at least three phosphorylated protein bands (with gel electrophoresis) were found to be sensitive to exogeneous cAMP-dependent protein kinase (e.g., Carstens and Weller, 1981; Barany and Barany, 1981; Carty, Economou, and Sperelakis, unpublished observations) . The functions of these membrane proteins have not yet been identified. One of these phosphorylatable peptides may represent the putative modulator of the slow channels (Rinaldi et al., 1981 (Rinaldi et al., , 1982 . It has been proposed that the cAMP-dependent phosphorylation could induce a conformational change in the slow channel protein so as to make it available for voltage activation (Sperelakis and Schneider, 1976) . (It is possible that cAMP injection exerts its effect on the sarcoplasmic reticulum (SR) to directly or indirectly (by increasing Ca ++ uptake into the SR via phospholamban) increase the release of Ca ++ from the SR, and hence increase [Ca]i; this, in turn, could increase gsi and I si (Isenberg, 1977; Marban and Tsien, 1982) and thereby potentiate the slow APs.)
The activated channels may become dephosphorylated by the action of a phosphatase and return to an inactive or less active state. Diacetylmonoxime was shown to depress both the AP plateau and the slow AP in cardiac Purkinje fibers due to a phosphatase-like action (Bergey, 1978) . Further intracellular injection experiments have been planned to test the phosphorylation hypothesis directly.
In conclusion, by direct intracellular injection experiments, evidence for a regulatory role of cAMP in cardiac slow channel function was obtained. The mechanism may involve the phosphorylation of a slow channel protein constituent by means of a cAMP-dependent protein kinase. The results further support the idea of cAMP being the intracellular mediator for the positive inotropic effect in cardiac muscle induced by yS-adrenergic agonists and histamine.
